269 related articles for article (PubMed ID: 795279)
1. MBD: advanced in understanding many bothersome dilemmas.
Seals JR
Adv Pediatr; 1976; 23():113-49. PubMed ID: 795279
[No Abstract] [Full Text] [Related]
2. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
[TBL] [Abstract][Full Text] [Related]
3. Minimal brain dysfunctions in children.
Peters JE
Am Fam Physician; 1974 Jul; 10(1):115-23. PubMed ID: 4834966
[No Abstract] [Full Text] [Related]
4. The hyperkinetic child: current status.
Dubey DR
Compr Ther; 1982 May; 8(5):58-67. PubMed ID: 7094561
[No Abstract] [Full Text] [Related]
5. Hyperactivity (attention-deficit disorder).
Martin CA; Welsh RJ; McKay SE; Bareuther CM
J Fam Pract; 1984 Sep; 19(3):367-9, 372-3, 376-7 passim. PubMed ID: 6381638
[TBL] [Abstract][Full Text] [Related]
6. Pemoline (Cylert) for minimal brain dysfunction.
Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
[No Abstract] [Full Text] [Related]
7. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
Eisenberg L
Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
[No Abstract] [Full Text] [Related]
8. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
Conners CK
Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
[No Abstract] [Full Text] [Related]
9. Mood-altering drugs and hyperkinetic children.
Erenberg G
Pediatrics; 1972 Feb; 49(2):308-11. PubMed ID: 5059542
[No Abstract] [Full Text] [Related]
10. A long-term comparison of two treatment regimens for minimal brain dysfunction. Drug therapy versus combined therapy.
Friedman R; Dale EP; Wagner JH
Clin Pediatr (Phila); 1973 Nov; 12(11):666-71. PubMed ID: 4759509
[No Abstract] [Full Text] [Related]
11. Psychosocial treatments for attention-deficit/hyperactivity disorder in children.
Barkley RA
J Clin Psychiatry; 2002; 63 Suppl 12():36-43. PubMed ID: 12562060
[TBL] [Abstract][Full Text] [Related]
12. The hyperactive child.
Millichap JG
Practitioner; 1976 Jul; 217(1297):61-5. PubMed ID: 995827
[No Abstract] [Full Text] [Related]
13. Attention-deficit/hyperactivity disorder: a life-span perspective.
Biederman J
J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
[TBL] [Abstract][Full Text] [Related]
14. The use of stimulant medication with children.
Phillips S
J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
[No Abstract] [Full Text] [Related]
15. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
[No Abstract] [Full Text] [Related]
16. Amphetamine-type drugs for hyperactive children.
Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
[No Abstract] [Full Text] [Related]
17. Growth disturbances in hyperkinetic children.
Greenhill LL; Puig-Antich J; Halpern F; Sachar EJ; Rubinstein B; Chambers W; Fiscina B; Florea J
Pediatrics; 1980 Jul; 66(1):152-4. PubMed ID: 7402783
[No Abstract] [Full Text] [Related]
18. The neurologic learning disability syndrome.
Silver LB
Am Fam Physician; 1971 Jul; 4(1):95-102. PubMed ID: 4934540
[No Abstract] [Full Text] [Related]
19. Clonidine for stimulant-related sleep problems.
Rubinstein S; Silver LB; Licamele WL
J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):281-2. PubMed ID: 8150803
[No Abstract] [Full Text] [Related]
20. Dextroamphetamine and methylphenidate in the treatment of hyperactive-aggressive children.
Winsberg BG; Press M; Bialer I; Kupietz S
Pediatrics; 1974 Feb; 53(2):236-41. PubMed ID: 4590730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
